Lara A.
- Country
- Italy
- Department
- UOC EMATOLOGIA
Research Overview
Data & Insights
Has run more than one trial at 52 of 82 partner sites.
Specializations
Hematologic Oncology
The investigator specializes in treating Acute Myeloid Leukemia (AML), with particular focus on cases presenting favorable to intermediate risk profiles. Their research interests center on understanding and treating abnormal blood cell proliferation disorders affecting the bone marrow.
- Blood Cell Development Disorders
- Myeloid Cell Differentiation
- Bone Marrow Pathologies
Therapeutic Innovation
Their clinical expertise extends to investigating novel therapeutic approaches combining targeted therapies with standard chemotherapy protocols. The investigator focuses on developing treatment strategies for hematologic malignancies.
- Combination Therapy Approaches
- Treatment Response Assessment
- Therapeutic Optimization
Disease Monitoring
The investigator has developed expertise in monitoring minimal residual disease (MRD) levels in blood disorders. Their work involves evaluating treatment effectiveness through precise disease response measurements.
- Disease Response Assessment
- Treatment Efficacy Monitoring
- Clinical Outcomes Evaluation
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.